The Significance of Skip Mediastinal Lymph Node Metastasis in the Prognosis of Patients with Resected Non-Small-Cell Lung Carcinoma: Is It Really a Better N2 Disease Subtype?

Seyrek Y., Cansever L., Metin M., Bolat E., Bedirhan M. A.

ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, vol.27, no.5, pp.304-310, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 5
  • Publication Date: 2021
  • Doi Number: 10.5761/atcs.oa.20-00289
  • Journal Name: ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Page Numbers: pp.304-310
  • Keywords: single-station N2 disease, skip metastasis, micrometastasis, lung cancer, ISOLATED TUMOR-CELLS, CANCER, CLASSIFICATION, RECURRENCE
  • Istanbul University Affiliated: Yes

Abstract

Objective: In this study, we aimed to reveal the prognostic differences between skip and non-skip metastasis mediastinal lymph node (MLN) metastasis.